ArticleWorld journal of oncology2024

Efficacy of First-Line Treatment With Pertuzumab and Trastuzumab in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Routine Clinical Practice.

Natalia Camejo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.